# US 6,727,079 B1 · cDNA encoding a gene BOG (B5T Over-expressed Gene) and its protein product

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,727,079 B1
- Document ID: US6727079B1
- Status: Granted
- Kind: B1
- Application number: 09/637,746
- Filed: 2000-08-11
- Granted: 2004-04-27
- Earliest claimed: 1998-02-25
- Assignees: The United States of America as represented by the Department of Health and Human Services
- Inventors: Snorri S. Thorgeirsson; Joseph T. Woitach; Minghuang Zhang
- Web page: https://patentgrep.com/patent/US6727079B1

## CPC

- C07K 14/4738: {Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR (cell cycle dependent kinases C12N9/12)}
- C07K 2317/24: containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
- C07K 2319/00: Fusion polypeptide
- Y10S 530/828: Cancer
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- Y10S: TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS

## Abstract

Nucleic acids that encode novel polypeptides, designated in the present application as “BOG” (B5T Over-expressed Gene) are provided. BOG binds to pRb and is over-expressed in a number transformed rat liver epithelial (RLE) cell lines resistant to the growth inhibitory effect of TGF-β1 as well as in primary liver tumors. Compositions including BOG chimeras, nucleic acids encoding BOG and antibodies to BOG are also provided. Methods of using BOG to modulate pRb-protein interactions and to alter cellular phenotype are further provided.

## Claims

### Claim 1

An isolated nucleic acid comprising a polynucleotide encoding a polypeptide comprising:
(i) at least about 90 percent amino acid sequence identity with SEQ ID NO: 2, SEQ ID NO: 8, or SEQ ID NO: 10;
(ii) a restinoblastoma gene product (pRB) binding motif; and
(iii) at least one casein II phosphorylation motif;
wherein the polypeptide binds pRB and displaces E2F-1 bound to pRB.

### Claim 2 (depends on 1)

The nucleic acid of claim 1, comprising a polynucleotide coding for SEQ ID NO: 2, SEQ ID NO: 8, or SEQ ID NO: 10.

### Claim 3 (depends on 1)

The nucleic acid of claim 1, wherein the nucleic acid sequence is codon optimized for a specific host cell.

### Claim 4 (depends on 1)

The nucleic acid of claim 1, joined to a detectable label.

### Claim 5 (depends on 1)

The nucleic acid of claim 1, wherein the DNA is cDNA.

### Claim 6 (depends on 1)

The nucleic acid of claim 1, wherein the nucleic acid is RNA.

### Claim 7 (depends on 6)

The nucleic acid of claim 6, wherein the ETA is mRNA.

### Claim 8 (depends on 1)

A vector comprising a polynucleotide encoding the polypeptide of claim 1.

### Claim 9 (depends on 8)

The vector of claim 8, wherein the nucleic acid is operably linked to at least one control sequence capable of being recognized by an isolated host cell transformed with the vector.

### Claim 10 (depends on 9)

An isolated host cell comprising the vector of claim 9.

### Claim 11 (depends on 1)

The isolated nucleic acid of claim 1, comprising a polynucleotide encoding a polypeptide comprising at least about 95 percent amino acid sequence identity with SEQ ID NO: 2, SEQ ID NO: 8, or SEQ ID NO: 10.

### Claim 12

An isolated nucleic acid comprising a polynucleotide that encodes a polypeptide having an amino acid sequence of SEQ ID NO:2, SEQ ID NO:8, or SEQ ID NO:10.

### Claim 13 (depends on 12)

A vector comprising a polynucleotide encoding the polypeptide of claim 12.

### Claim 14 (depends on 13)

The vector of claim 13, wherein the polynucleotide is operably linked to at least one control sequence capable of being recognized by an isolated host cell transformed with the vector.

### Claim 15 (depends on 14)

An isolated host cell comprising the vector of claim 14.

### Claim 16 (depends on 10)

A method of producing a polypeptide comprising (i) at least about 90 percent amino acid sequence identity with SEQ ID NO: 2, SEQ ID NO: 8, or SEQ ID NO: 10; (ii) a restinoblastoma gene product (pRB) binding motif; and (iii) at least one casein II phosphorylation motif; wherein the polypeptide binds pRB and displaces E2F-1 bound to pRB; comprising culturing the isolated host cell of claim 10 under conditions suitable for production of the polypeptide.

### Claim 17 (depends on 1)

An isolated nucleic acid according to claim 1, wherein the isolated nucleic acid has a polynucleotide sequence of SEQ ID NO: 1 or the full length complement thereof.

### Claim 18 (depends on 1)

An isolated nucleic acid according to claim 1, wherein the isolated nucleic acid has a polynucleotide sequence of SEQ ID NO: 7 or the full length complement thereof.

### Claim 19 (depends on 1)

An isolated nucleic acid according to claim 1, wherein the isolated nucleic acid has a polynucleotide sequence of SEQ ID NO: 9 or the full length complement thereof.
